An expert committee appointed by provincial and federal governments concludes the abortion drug Mifegymiso should be paid for by the public health-care system after a review of its efficacy and safety.
An expert committee appointed by provincial and federal governments concludes the abortion drug Mifegymiso should be paid for by the public health-care system after a review of its efficacy and safety.